Result Summary for 109801
| Protocol ID: | 109801 |
| Clinical Study ID: | 109801 |
| Official Title: | Complementary testing to further evaluate the immunogenicity of a GSK Biologicals’ HPV vaccine (580299) in healthy female subjects aged over 26 years enrolled in study 104820. |
| Phase: | phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | Human Papillomavirus Types 16 and 18 Vaccine |
| Trade/Product Name: | Cervarix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
